These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35715588)

  • 1. Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease.
    Romanos SG; Srinath A; Li Y; Xie B; Chen C; Li Y; Moore T; Bi D; Sone JY; Lightle R; Hobson N; Zhang D; Koskimäki J; Shen L; McCurdy S; Lai CC; Stadnik A; Piedad K; Carrión-Penagos J; Shkoukani A; Snellings D; Shenkar R; Sulakhe D; Ji Y; Lopez-Ramirez MA; Kahn ML; Marchuk DA; Ginsberg MH; Girard R; Awad IA
    Transl Stroke Res; 2023 Aug; 14(4):513-529. PubMed ID: 35715588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel CCM1 (KRIT1) Mutation Detection in Brazilian Familial Cerebral Cavernous Malformation: Different Genetic Variants in Inflammation, Oxidative Stress, and Drug Metabolism Genes Affect Disease Aggressiveness.
    Fontes-Dantas FL; da Fontoura Galvão G; Veloso da Silva E; Alves-Leon S; Cecília da Silva Rêgo C; Garcia DG; Marques SA; Blanco Martinez AM; Reis da Silva M; Marcondes de Souza J
    World Neurosurg; 2020 Jun; 138():535-540.e8. PubMed ID: 32113992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene mutations in patients with hereditary cavernous malformations].
    Belousova OB; Bulygina ES; Okishev DN; Prohorchuk EB; Tsygankova SV; Pronin IN; Shishkina LV; Ryzhova MV; Skryabin KG; Konovalov AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):66-72. PubMed ID: 28745674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease.
    Goitre L; Fornelli C; Zotta A; Perrelli A; Retta SF
    Methods Mol Biol; 2020; 2152():151-167. PubMed ID: 32524551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations.
    Kar S; Bali KK; Baisantry A; Geffers R; Samii A; Bertalanffy H
    J Mol Neurosci; 2017 Feb; 61(2):178-188. PubMed ID: 28181149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease.
    Perrelli A; Retta SF
    Free Radic Biol Med; 2021 Aug; 172():403-417. PubMed ID: 34175437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
    Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
    J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of Two Families with New Mutations in Familial Cerebral Cavernous Malformations Genes.
    Iruzubieta P; Campo-Caballero D; Equiza J; Albajar I; Sulibarría N; Sáez R; Andrés N; Mondragón E; Zulaica M; de Arce A; Urtasun M; López de Munain A
    J Stroke Cerebrovasc Dis; 2021 Dec; 30(12):106130. PubMed ID: 34597987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
    Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
    Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Report of Concomitant Pathogenic Mutations Within MGC4607/CCM2 and KRIT1/CCM1 in a Familial Cerebral Cavernous Malformation Patient.
    da Fontoura Galvão G; Veloso da Silva E; Fontes-Dantas FL; Filho RC; Alves-Leon S; Marcondes de Souza J
    World Neurosurg; 2020 Oct; 142():481-486.e1. PubMed ID: 32615293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
    Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
    Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel CCM1/KRIT1 heterozygous deletion mutation (c.1919delT) in a Chinese family with familial cerebral cavernous malformation.
    Yang C; Wu B; Zhong H; Li Y; Zheng X; Xu Y
    Clin Neurol Neurosurg; 2018 Jan; 164():44-46. PubMed ID: 29169046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial cerebral cavernous malformation: Report of a novel KRIT1 mutation in a Portuguese family.
    Rosário Marques I; Antunes F; Ferreira N; Grunho M
    Seizure; 2017 Dec; 53():72-74. PubMed ID: 29145060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
    Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
    J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective autophagy is a key feature of cerebral cavernous malformations.
    Marchi S; Corricelli M; Trapani E; Bravi L; Pittaro A; Delle Monache S; Ferroni L; Patergnani S; Missiroli S; Goitre L; Trabalzini L; Rimessi A; Giorgi C; Zavan B; Cassoni P; Dejana E; Retta SF; Pinton P
    EMBO Mol Med; 2015 Nov; 7(11):1403-17. PubMed ID: 26417067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
    Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
    Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRIT1 Gene in Patients with Cerebral Cavernous Malformations: Clinical Features and Molecular Characterization of Novel Variants.
    Ricci C; Cerase A; Riolo G; Manasse G; Battistini S
    J Mol Neurosci; 2021 Sep; 71(9):1876-1883. PubMed ID: 33651268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.
    Antognelli C; Trapani E; Delle Monache S; Perrelli A; Daga M; Pizzimenti S; Barrera G; Cassoni P; Angelucci A; Trabalzini L; Talesa VN; Goitre L; Retta SF
    Free Radic Biol Med; 2018 Feb; 115():202-218. PubMed ID: 29170092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
    McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
    Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous findings of familial cerebral cavernous malformation syndrome due to the common Hispanic mutation.
    Manole AK; Forrester VJ; Zlotoff BJ; Hart BL; Morrison LA
    Am J Med Genet A; 2020 May; 182(5):1066-1072. PubMed ID: 32100472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.